APAF1 partially abrogated paclitaxel resistance (Fig. 6b), suggesting that besides downregulation of AFAP1, other mechanisms are involved in mediating the effect of miR21 on paclitaxel resistance in ovarian cancer cells. Here, AFAP1 is linked to ovarian carcinoma.